--Morgan Stanley Lowers Price Target for Pacific Biosciences of California to $10 From $14, Maintains Equalweight Rating
9:28AM ET 8/04/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...